The AACU has joined more than 20 other organizations in supporting biomarker testing legislation introduced in Ohio. This legislation would ensure that Ohioans covered by state-regulated insurance plans, including Medicaid, have coverage for biomarker testing when medically appropriate. Improving access to biomarker testing and thereby access to targeted therapies is also an important strategy to reduce health disparities and improve outcomes for cancer patients. Read more
Recent Posts
- The Silent Epidemic: AACU and Man vs Prostate Call for a National Pivot Toward Bladder Health
- AACU Supports the Legislative Spirt of the Break Up Medicine Act
- AACU Supports H.R. 7602 which Seeks to Establish an Office of Men’s Health within the Department of Health and Human Services
- John Lam, MD, Outlines Key Policy Priorities to Streamline Prior Authorization in Urology
- AACU Publicly Supports Maine LD 107 Titled “An Act to Require Health Insurance Coverage for Biomarker Testing.”
Recent Comments
No comments to show.